4249
MORIROKU COMPANY,LTD.
森六
- Industry
- Chemicals
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2021
155,460
Mar 2022
128,842
Mar 2023
142,019
Mar 2024
145,638
Mar 2025
146,174
Operating profit(million JPY)
Mar 2021
5,672
Mar 2022
2,846
Mar 2023
1,335
Mar 2024
5,706
Mar 2025
4,135
Operating profit margin(%)
Mar 2021
3.65
Mar 2022
2.21
Mar 2023
0.94
Mar 2024
3.92
Mar 2025
2.83
Profit before tax(million JPY)
Mar 2021
2,596
Mar 2022
7,915
Mar 2023
3,407
Mar 2024
4,974
Mar 2025
-6,571
Profit(million JPY)
Mar 2021
375
Mar 2022
4,259
Mar 2023
1,346
Mar 2024
3,022
Mar 2025
-7,814
Total assets(million JPY)
Mar 2021
132,887
Mar 2022
137,125
Mar 2023
131,797
Mar 2024
140,556
Mar 2025
124,634
Cash and cash equivalents(million JPY)
Mar 2021
17,933
Mar 2022
18,358
Mar 2023
17,658
Mar 2024
19,444
Mar 2025
19,088
Cash flows from operating activities(million JPY)
Mar 2021
9,693
Mar 2022
3,434
Mar 2023
9,495
Mar 2024
14,764
Mar 2025
9,348
Cash flows from investing activities(million JPY)
Mar 2021
-5,260
Mar 2022
-1,140
Mar 2023
-5,311
Mar 2024
-6,630
Mar 2025
-3,751
Cash flows from financing activities(million JPY)
Mar 2021
1,633
Mar 2022
-2,824
Mar 2023
-5,310
Mar 2024
-7,221
Mar 2025
-6,407
Return on equity(%)
Mar 2021
0.56
Mar 2022
6.11
Mar 2023
1.92
Mar 2024
4.18
Mar 2025
-
Equity ratio(%)
Mar 2021
51.78
Mar 2022
51.55
Mar 2023
52.6
Mar 2024
53.44
Mar 2025
51.08
Earnings per share(JPY per share)
Mar 2021
22.68
Mar 2022
258.92
Mar 2023
86.34
Mar 2024
200.95
Mar 2025
-532.37
Net assets per share(JPY per share)
Mar 2021
4,152.57
Mar 2022
4,423.86
Mar 2023
4,548.62
Mar 2024
5,069.98
Mar 2025
4,342.56
Dividend per share(JPY per share)
Mar 2021
50
Mar 2022
94
Mar 2023
100
Mar 2024
100
Mar 2025
105
Payout ratio(%)
Mar 2021
220.46
Mar 2022
36.3
Mar 2023
115.82
Mar 2024
49.76
Mar 2025
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.